Acute nephrotoxicity of aristolochic acid in vitro: metabolomics study for intracellular metabolic time-course changes

References

• An SZ, Bleu T, Zheng YH, Goetzl EJ. (1998). Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. Mol Pharmacol 54:881–8
   PubMed Web of Science ®Google Scholar
• Arian R, van Erkela PMTP. (1998). Receiver operating characteristic (ROC) analysis: basic principles and applications in radiology. Eur J Radiol 27:88–94
   PubMed Web of Science ®Google Scholar
• Berridge MJ. (1993). Inositol trisphosphate and calcium signalling. Nature 361:315–25
   PubMed Web of Science ®Google Scholar
• Chan ECY, Pasikanti KK, Nicholson JK. (2011). Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nature Protocols 6:1483–99
   PubMed Web of Science ®Google Scholar
• Chan W, Cai Z. (2008). Aristolochic acid induced changes in the metabolic profile of rat urine. J Pharmaceut Biomed Anal 46:757–62
   PubMed Web of Science ®Google Scholar
• Chan W, Lee K-C, Liu N, et al. (2008). Liquid chromatography/mass spectrometry for metabonomics investigation induced by aristolochic acid of the biochemical effects in rats: the use of information-dependent acquisition for biomarker identification. Rapid Commun Mass Spectrom 22:873–80
   PubMed Web of Science ®Google Scholar
• Chen J, Zhao X, Fritsche J, et al. (2008). Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information. Analyt Chem 80:1280–9
   PubMed Web of Science ®Google Scholar
• Chen MJ, Su MM, Zhao LP, et al. (2006). Metabonomic study of aristolochic acid-induced nephrotoxicity in rats. J Proteome Res 5:995–1002
   PubMed Web of Science ®Google Scholar
• Chen S, Kong H, Lu X, et al. (2013). Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry. Anal Chem 85:8326–33
   PubMed Web of Science ®Google Scholar
• Clapham DE. (1995). Calcium signaling. Cell 80:259–68
   PubMed Web of Science ®Google Scholar
• Debelle FD, Nortier JL, De Prez EG, et al. (2002). Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats. J Am Soc Nephrol 13:431–6
   PubMed Web of Science ®Google Scholar
• Derakhshanfar A, Bidadkosh A, Kazeminia S. (2007). Vitamin E protection against gentamicin-induced nephrotoxicity in rats: a biochemical and histopathologic study. Iranian J Veter Res 8:231–8
   Web of Science ®Google Scholar
• Fanburg BL, Lee SL. (1997). A new role for an old molecule: serotonin as a mitogen. Am J Physiol 272:L795–806
   PubMed Web of Science ®Google Scholar
• Gika HG, Theodoridis GA, Wingate JE, Wilson ID. (2007). Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J Proteome Res 6:3291–303
   PubMed Web of Science ®Google Scholar
• Goekmen MR, Cosyns J-P, Arlt VM, et al. (2013). The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review. Ann Internal Med 158:469–U132
   PubMed Web of Science ®Google Scholar
• Gomez-Lechon MJ, Castell JV, Donato MT. (2007). Hepatocytes – the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo. Chem Biol Interact 168:30–50
   PubMed Web of Science ®Google Scholar
• Grollman AP. (2013). Aristolochic acid nephropathy: harbinger of a global iatrogenic disease. Environ Mol Mutagenesis 54:1–7
   PubMed Web of Science ®Google Scholar
• Gunness P, Aleksa K, Kosuge K, et al. (2010). Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity. Can J Physiol Pharmacol 88:448–55
   PubMed Web of Science ®Google Scholar
• Hanafy S, Soltan ME. (2004). Effects of Vitamin E pretreatment on subacute toxicity of mixture of Co, Pb, and Hg nitrate-induced nephrotoxicity in rats. Environ Toxicol Pharmacol 17:159–67
   PubMed Web of Science ®Google Scholar
• Heinrich M, Chan J, Wanke S, et al. (2009). Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2-A global assessment based on bibliographic sources. J Ethnopharmacol 125:108–44
   PubMed Web of Science ®Google Scholar
• Hooks SB, Ragan SP, Hopper DW, et al. (1998). Characterization of a receptor subtype-selective lysophosphatidic acid mimetic. Mol Pharmacol 53:188–94
   PubMed Web of Science ®Google Scholar
• Huang JK, Jan CR. (2001). Linoleamide, a brain lipid that induces sleep, increases cytosolic Ca2 + levels in MDCK renal tubular cells. Life Sci 68:997–1004
   PubMed Web of Science ®Google Scholar
• Huang Q, Tan Y, Yin P, et al. (2013). Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res 73:4992–5002
   PubMed Web of Science ®Google Scholar
• Huang Q, Yin P, Wang J, et al. (2011). Method for liver tissue metabolic profiling study and its application in type 2 diabetic rats based on ultra performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879:961–7
   PubMed Web of Science ®Google Scholar
• Jan CR, Lu YC, Jiann BP, et al. (2003). Novel effect of N-palmitoyl-L-serine phosphoric acid on cytosolic Ca2 + levels in human osteoblasts. Pharmacol Toxicol 93:71–6
   PubMedGoogle Scholar
• Lenz EM, Bright J, Knight R, et al. (2004). A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using H-1 NMR and HPLC-TOF/MS: time dependant changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. Analyst 129:535–41
   PubMed Web of Science ®Google Scholar
• Li T, Francl JM, Boehme S, et al. (2012). Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J Biol Chem 287:1861–73
   PubMed Web of Science ®Google Scholar
• Li XM, Wang HY. (2004). Aristolochic acid nephropathy: what we know and what we have to do. Nephrology 9:109–11
   PubMed Web of Science ®Google Scholar
• Lin S, Chan W, Li J, Cai Z. (2010). Liquid chromatography/mass spectrometry for investigating the biochemical effects induced by aristolochic acid in rats: the plasma metabolome. Rapid Commun Mass Spectrom 24:1312–18
   PubMed Web of Science ®Google Scholar
• Liu X, Xiao Y, Gao H-C, et al. (2010). Metabonomic study of aristolochic acid i-induced acute renal toxicity urine at female and male C57BL/6J mice based on H-1 NMR. Chem J Chin Univ 31:927–32
   Web of Science ®Google Scholar
• Lou Y, Li J, Lu Y, et al. (2011). Aristolochic acid-induced destruction of organic ion transporters and fatty acid metabolic disorder in the kidney of rats. Toxicol Lett 201:72–9
   PubMed Web of Science ®Google Scholar
• Mengs U, Stotzem CD. (1993). Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology. Arch Toxicol 67:307–11
   PubMed Web of Science ®Google Scholar
• Michl J, Jennings HM, Kite GC, et al. (2013). Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach. J Ethnopharmacol 149:235–44
   PubMed Web of Science ®Google Scholar
• Moder M, Kiessling A, Loster H. (2005). Current methods for determination of L-carnitine and acylcarnitines. Monatshefte Fur Chemie 136:1279–91
   Web of Science ®Google Scholar
• Neidlinger NA, Larkin SK, Bhagat A, et al. (2006). Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem 281:775–81
   PubMed Web of Science ®Google Scholar
• Ni Y, Su M, Qiu Y, et al. (2007). Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat. FEBS Lett 581:707–11
   PubMed Web of Science ®Google Scholar
• Peraza MA, Carter DE, Gandolfi AJ. (2003). Toxicity and metabolism of subcytotoxic inorganic arsenic in human renal proximal tubule epithelial cells (HK-2). Cell Biol Toxicol 19:253–64
   PubMed Web of Science ®Google Scholar
• Pizzinat N, Girolami JP, Parini A, et al. (1999). Serotonin metabolism in rat mesangial cells: Involvement of a serotonin transporter and monoamine oxidase A. Kidney Int 56:1391–9
   PubMed Web of Science ®Google Scholar
• Poon SL, Pang S-T, McPherson JR, et al. (2013). Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci Trans Med 5:1–10
   Web of Science ®Google Scholar
• Sahi J, Grepper S, Smith C. (2010). Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery. Curr Drug Discov Technol 7:188–98
   PubMedGoogle Scholar
• Schmeiser HH, Bieler CA, Wiessler M, et al. (1996). Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 56:2025–8
   PubMed Web of Science ®Google Scholar
• Shen G, Chen Y, Sun J, et al. (2011). Time-course changes in potential biomarkers detected using a metabonomic approach in Walker 256 tumor-bearing rats. J Proteome Res 10:1953–61
   PubMed Web of Science ®Google Scholar
• Stiborova M, Frei E, Wiessler M, Schmeiser HH. (2001). Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2. Chem Res Toxicol 14:1128–37
   PubMed Web of Science ®Google Scholar
• Takuwa N, Ganz M, Takuwa Y, et al. (1989). Studies of the mitogenic effect of serotonin in rat renal mesangial cells. Am J Physiol 257:F431–9
   PubMed Web of Science ®Google Scholar
• Tan Y, Yin P, Tang L, et al. (2012). Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis. Mol Cellular Proteomics 11: M111.010694–M111.94
   PubMed Web of Science ®Google Scholar
• Tautenhahn R, Patti GJ, Rinehart D, Siuzdak G. (2012). XCMS online: a web-based platform to process untargeted metabolomic data. Analyt Chem 84:5035–9
   PubMed Web of Science ®Google Scholar
• Vanherweghem JL, Depierreux M, Tielemans C, et al. (1993). Rapidly progressive interstitial renal fibrosis in young-women – association with slimming regimen including Chinese herbs. Lancet 341:387–91
   PubMed Web of Science ®Google Scholar
• Wang YQ, Berndt TJ, Gross JM, et al. (2001). Effect of inhibition of MAO and COMT on intrarenal dopamine and serotonin and on renal function. Am J Physiol Regul Integr Comp Physiol 280:R248–54
   PubMed Web of Science ®Google Scholar
• Wu Y, Connors D, Barber L, et al. (2009). Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds. Toxicol In Vitro 23:1170–8
   PubMed Web of Science ®Google Scholar
• Xia J, Mandal R, Sinelnikov IV, et al. (2012). MetaboAnalyst 2.0 – a comprehensive server for metabolomic data analysis. Nucleic Acids Res 40:W127–33
   PubMed Web of Science ®Google Scholar
• Xia J, Psychogios N, Young N, Wishart DS. (2009). MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 37:W652–60
   PubMed Web of Science ®Google Scholar
• Zager RA. (1999). Calcitriol directly sensitizes renal tubular cells to ATP-depletion- and iron-mediated attack. Am J Pathol 154:1899–909
   PubMed Web of Science ®Google Scholar
• Zhao YY, Cheng XL, Vaziri ND, et al. (2014). UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry. Clin Biochem 47:16–26
   PubMed Web of Science ®Google Scholar
• Zhao Y-Y, Lin R-C. (2014a). Metabolomics in nephrotoxicity. In: Makowski GS, ed. Advances in clinical chemistry. Vol. 65. San Diego, CA: Elsevier Academic Press Inc., 69–89
   Google Scholar
• Zhao Y-Y, Lin RC. (2014b). UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics. Chem Biol Interact 215:7–16
   PubMed Web of Science ®Google Scholar
• Zhao Y-Y, Tang D-D, Chen H, et al. (2015). Urinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS. Bioanalysis 7:685–700
   PubMed Web of Science ®Google Scholar
• Zhao Y-Y, Wang H-L, Cheng X-L, et al. (2015). Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy. Sci Rep 5:12936
   PubMed Web of Science ®Google Scholar